TrialJournal of neurology2020
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis.
Teresa Coelho et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled itcites it